181 related articles for article (PubMed ID: 19476417)
1. Effects of hawthorn on the progression of heart failure in a rat model of aortic constriction.
Hwang HS; Boluyt MO; Converso K; Russell MW; Bleske BE
Pharmacotherapy; 2009 Jun; 29(6):639-48. PubMed ID: 19476417
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hawthorn extract on immunomodulatory biomarkers in a pressure overload model of heart failure.
Bleske BE; Zineh I; Hwang HS; Welder GJ; Ghannam MM; Boluyt MO
Med Sci Monit; 2007 Dec; 13(12):BR255-8. PubMed ID: 18049426
[TBL] [Abstract][Full Text] [Related]
3. Effects of hawthorn on cardiac remodeling and left ventricular dysfunction after 1 month of pressure overload-induced cardiac hypertrophy in rats.
Hwang HS; Bleske BE; Ghannam MM; Converso K; Russell MW; Hunter JC; Boluyt MO
Cardiovasc Drugs Ther; 2008 Feb; 22(1):19-28. PubMed ID: 18210194
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of immunomodulatory biomarkers in a pressure overload model of heart failure.
Bleske BE; Hwang HS; Zineh I; Ghannam MG; Boluyt MO
Pharmacotherapy; 2007 Apr; 27(4):504-9. PubMed ID: 17381376
[TBL] [Abstract][Full Text] [Related]
5. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
7. Novel experimental model of pressure overload hypertrophy in rats.
Molina EJ; Gupta D; Palma J; Torres D; Gaughan JP; Houser S; Macha M
J Surg Res; 2009 May; 153(2):287-94. PubMed ID: 18755480
[TBL] [Abstract][Full Text] [Related]
8. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats.
Ciobotaru V; Heimburger M; Louedec L; Heymes C; Ventura-Clapier R; Bedossa P; Escoubet B; Michel JB; Mercadier JJ; Logeart D
J Pharmacol Exp Ther; 2008 Jan; 324(1):43-9. PubMed ID: 17901295
[TBL] [Abstract][Full Text] [Related]
10. 3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.
Cirrincione GM; Boluyt MO; Hwang HS; Bleske BE
J Cardiovasc Pharmacol; 2006 Apr; 47(4):521-30. PubMed ID: 16680065
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
12. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload.
Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
He J; Chen Y; Huang Y; Yao F; Wu Z; Chen S; Wang L; Xiao P; Dai G; Meng R; Zhang C; Tang L; Huang Y; Li Z
Eur J Pharmacol; 2009 Jan; 602(1):132-7. PubMed ID: 19027731
[TBL] [Abstract][Full Text] [Related]
15. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
17. Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy.
Molina EJ; Palma J; Gupta D; Torres D; Gaughan JP; Houser S; Macha M
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):292-9, 299.e1. PubMed ID: 18242254
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure.
Zheng X; Wang S; Zou X; Jing Y; Yang R; Li S; Wang F
Exp Anim; 2017 Aug; 66(3):217-228. PubMed ID: 28367863
[TBL] [Abstract][Full Text] [Related]
20. Health effects of hawthorn.
Dahmer S; Scott E
Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
